Company: BNBX
Filing Date: 2025-01-10
Form Type: S-1/A
Source: 0001104659-25-002521
Chunk: 33

Company: BNB PLUS CORP.
Filing Date: 2025-01-10
Form: S-1/A
Chunk 33
---
services or any other expenses incurred by the Selling Stockholders in disposing of their shares of Common Stock. We will bear all other
costs, fees and expenses incurred in effecting the registration of the shares covered by this prospectus, including, without limitation,
all registration fees and fees and expenses of our counsel and our accountants.

<div align='center'>MARKET PRICE OF OUR COMMON STOCK AND RELATED STOCKHOLDER MATTERS</div>

Market Information

Our Common Stock is listed on The Nasdaq Capital
Market under the symbol “APDN.” A description of our Common Stock is set forth under the heading “Description of Capital
Stock” beginning on page 19 of this prospectus.

The last reported sale price for our Common Stock on January 8,
2025 was $0.20 per share.

Holders

As of January 8, 2025, we had 376 record holders
of our Common Stock and no preferred stock issued and outstanding. The number of record holders was determined from the records
of our transfer agent and does not include beneficial owners of Common Stock whose shares are held in the names of various security brokers,
dealers, and registered clearing agencies. The transfer agent of our Common Stock is Equiniti Trust Company, LLC. The transfer agent
and registrar’s address is 90 Park Avenue, New York, NY 10016.

<div align='center'>13</div>

Dividend Policy

The Company has never previously declared
or paid any cash dividends on its Common Stock. We currently intend to retain earnings and profits, if any, to support our business strategy
and do not intend to pay any cash dividends within the foreseeable future. Any future determination to pay cash dividends will be at
the sole discretion of our Board of Directors and will depend upon the financial condition of the Company, its operating results, capital
requirements, general business conditions and any other factors that our Board of Directors deems relevant.

<div align='center'>PRIVATE PLACEMENT OF WARRANTS</div>

Concurrently with the sale of shares of Common Stock and Pre-Funded Warrants, we also issued and sold to the Selling Stockholders the
Private Warrants to purchase an aggregate of up to 41,640,625 shares of our Common Stock, consisting of (i) 20,312,500 Series C
Warrants, (ii) 20,312,500 Series D Warrants and (iii) 1,015,625 Placement Agent Warrants.

The exercisability of the Private Placement